instruction
stringlengths 30
82
| output
stringlengths 13
790
|
|---|---|
What is the type of genetic variation for RS1304775415 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1304775415 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593534695 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593534695 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593534695 SNP. |
In which chromosome is RS1593534695 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593534695 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593534695 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593534695 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593534695 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593534695 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593534695 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1014225642 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1014225642 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1014225642 SNP. |
In which chromosome is RS1014225642 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1014225642 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1014225642 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1014225642 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1014225642 SNP? | The origin is germline. |
What is the type of genetic variation for RS1014225642 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1014225642 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS762092062 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS762092062 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS762092062 SNP. |
In which chromosome is RS762092062 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS762092062 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS762092062 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS762092062 SNP? | The variation length is 1 base pairs. |
What is the origin for RS762092062 SNP? | The origin is germline. |
What is the type of genetic variation for RS762092062 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS762092062 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593532069 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593532069 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593532069 SNP. |
In which chromosome is RS1593532069 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593532069 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593532069 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593532069 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593532069 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593532069 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593532069 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS371894780 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS371894780 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS371894780 SNP. |
In which chromosome is RS371894780 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS371894780 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS371894780 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS371894780 SNP? | The variation length is 1 base pairs. |
What is the origin for RS371894780 SNP? | The origin is germline. |
What is the type of genetic variation for RS371894780 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS371894780 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS750057315 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS750057315 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS750057315 SNP. |
In which chromosome is RS750057315 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS750057315 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS750057315 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS750057315 SNP? | The variation length is 1 base pairs. |
What is the origin for RS750057315 SNP? | The origin is germline. |
What is the type of genetic variation for RS750057315 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS750057315 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593411898 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593411898 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593411898 SNP. |
In which chromosome is RS1593411898 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593411898 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593411898 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593411898 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593411898 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593411898 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593411898 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1060504823 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1060504823 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1060504823 SNP. |
In which chromosome is RS1060504823 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1060504823 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1060504823 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1060504823 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1060504823 SNP? | The origin is germline. |
What is the type of genetic variation for RS1060504823 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1060504823 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS1060504824 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1060504824 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1060504824 SNP. |
In which chromosome is RS1060504824 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1060504824 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1060504824 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1060504824 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1060504824 SNP? | The origin is germline. |
What is the type of genetic variation for RS1060504824 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1060504824 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593539513 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593539513 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593539513 SNP. |
In which chromosome is RS1593539513 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593539513 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593539513 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593539513 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593539513 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593539513 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593539513 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1555284937 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1555284937 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1555284937 SNP. |
In which chromosome is RS1555284937 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1555284937 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1555284937 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1555284937 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1555284937 SNP? | The origin is germline. |
What is the type of genetic variation for RS1555284937 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1555284937 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593547275 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593547275 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593547275 SNP. |
In which chromosome is RS1593547275 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593547275 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593547275 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593547275 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593547275 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593547275 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593547275 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593446655 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593446655 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593446655 SNP. |
In which chromosome is RS1593446655 SNP located? | It is located in the chromosome 13. |